Make a contribution and receive your TMJ wristband!

"Changing The Face of TMJ"
 
 What's New
  • View our Oct/Nov E-Newsletter, TMJ News Bites
  • TMJ Clinical Trial Opportunity
  • Local Anesthetics, Continuously Infused (marketed as bupivacaine, chlorprocaine, lidocaine, mepivacaine, procaine, ropivacaine) - Chondrolysis
  • FDA Wins Court Case on All Counts Against Tmj Implants, Inc.
  • TMJ Bioengineering Conference Nov 4-7
  • Review of Arthrocentesis and lavage treatments
  • NIH Grant Opportunities
  • Breakthrough: Bone Graft Grown in Exact Shape of Complex Skull-Jaw Joint
  • Antidepressants in Pregnancy Up Heart Defect Risk
  • WeAreTMJ.org
  • Become a TMJA Advisor
  • Workplace Campaigns
  • TMJD Clinical Trial Now Recruiting
  • Archives
     
  •  My Profile
  • Update Profile
  • Forgot Password?
  • Register




  • iGive.com  


    TMJA's Combined Federal Campaign #12102

    Sign up for our E-mail Newsletter, TMJ News Bites
      First Time Visitor?
    Did you know…approx. 35 million people in the United States suffer from TMJ problems.
  • TMJD Overview
  • Common Treatments
  • Self-care Tips
  • Who Treats TMJDs?
  • Questions You Should Ask
  • Need Support?

  •  We Need You!
                      Get Involved!
  • Donate
  • Register with the TMJA
  • Join TMJD Voices Campaign
  • Write your Elected Officials
  • Volunteer



  • What's New - Late Breaking News

    Wednesday, October 07, 2009

    Research Grant Opportunities

    * NIH Blueprint for Neuroscience Research Competitive Revisions for Studies Focused on Neuropathic Pain or Neural Plasticity to Promote Collaborative Pain Research (R01)
    Deadline: November 23, 2009

    The NIH Blueprint for Neuroscience Research has announced a funding opportunity that will support partnerships between scientists from the pain and neuroplasticity fields. These partnerships are expected to lead to insights into the neuroplastic changes that occur during the transition from acute to chronic pain.

    In the next two years, this Blueprint initiative will be expanded to promote larger collaborative projects on the transition from acute to chronic pain, and to train new investigators in state-of-the-art methods for studying pain.



    * Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Probe Production Centers Network (MLPCN) (R03)
    Released Date: March 12, 2009

    http://grants.nih.gov/grants/guide/pa-files/PAR-09-129.html.
    The NIH Molecular Libraries Roadmap Initiative wishes to encourage HTS assay applications from investigators who have the interest and capability to work with the Molecular Libraries Probe Production Centers Network (MLPCN) for chemical probe development. This Funding Opportunity Announcement (FOA) promotes discovery and development of new chemical probes as research tools for use by scientists in both the public and private sectors to advance the understanding of biological functions and disease mechanisms. This initiative is one of the integrated components of the NIH Molecular Libraries Roadmap initiative that offers biomedical researchers access to large-scale automated high throughput screening (HTS) centers in the MLPCN, diverse compound libraries in the Small Molecule Repository (MLSMR) and information on biological activities of small molecules in the PubChem BioAssay public database.

    * NIAMS Building Interdisciplinary Research Team (BIRT) Revision Awards - RFA) Number: RFA-AR-08-001

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
    Released Date: November 2, 2007

    Expiration Date: January 5, 2012

    http://grants2.nih.gov/grants/guide/rfa-files/RFA-AR-08-001.html.
    To promote interdisciplinary research, the NIAMS plans to provide up to 1 year of research revision support (formerly referred to as “supplement” – see page 1-21 section 2.8 of the SF424 (R&R) Application and Electronic Submission Instructions Version 2) to active NIAMS R01s (parent grants) to establish collaborations among groups of investigators with expertise in the specific areas listed below. The institute intends to supplement interdisciplinary collaboration with high innovation and potentially high impact in the specific NIAMS mission–relevant areas solicited in this FOA. It is understood that such an application may entail high risk. Teams developed under this award are expected to make significant advances beyond the progress expected from the individual researchers alone. Collaborations between scientific areas listed below are selected to pilot the NIAMS BIRT awards and specifically solicited in this FOA.
    • Autoimmunity – Gender and sex factors
    • Autoimmunity or Developmental biology – Systems biology
    • Soft tissue biology – Imaging technologies
    • Tissue engineering – Immunology or Developmental biology




    * The Biomarkers Consortium

    The Biomarkers Consortium, a research partnership managed by the Foundation for the National Institutes of Health, is soliciting concepts for biomarker projects. Researchers are encouraged to submit project concepts online at http://www.biomarkersconsortium.org. If a concept is approved for development by the consortium, the Foundation for NIH will seek funds to support the project.

    The consortium is a large-scale, public-private research partnership formed in 2006 to identify and qualify biomarkers. It encourages participation by academia, government, industry, patient advocacy groups and other non-profit organizations. In addition to the Foundation for NIH, founding members of the consortium include the NIH, the Food and Drug Administration and the Pharmaceutical Research and Manufacturers of America.

    Information about the Foundation for NIH is available at http://www.fnih.org.


    Past news items can be found in our News Archive